Falk AT - Search Results

1

Results of age-dependent anal canal cancer treatment: a single centre retrospective study.

Claren A, Doyen J, Falk AT, Benezery K, Follana P, Frin AC, Hannoun-Lévi JM, Cavaglione G, Mari V, Gérard JP, François E. Claren A, et al. Among authors: falk at. Dig Liver Dis. 2014 May;46(5):460-4. doi: 10.1016/j.dld.2014.01.004. Epub 2014 Feb 17. Dig Liver Dis. 2014. PMID: 24555918

2

Interstitial high-dose rate brachytherapy as boost for anal canal cancer.

Falk AT, Claren A, Benezery K, François E, Gautier M, Gerard JP, Hannoun-Levi JM. Falk AT, et al. Radiat Oncol. 2014 Nov 6;9:240. doi: 10.1186/s13014-014-0240-4. Radiat Oncol. 2014. PMID: 25377886 Free PMC article.

3

Mitomycin and 5-fluorouracil for second-line treatment of metastatic squamous cell carcinomas of the anal canal.

Saint A, Evesque L, Falk AT, Cavaglione G, Montagne L, Benezery K, Francois E. Saint A, et al. Among authors: falk at. Cancer Med. 2019 Nov;8(16):6853-6859. doi: 10.1002/cam4.2558. Epub 2019 Sep 16. Cancer Med. 2019. PMID: 31524335 Free PMC article.

4

High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.

Rouscoff Y, Falk AT, Durand M, Gal J, Chand ME, Gautier M, Marsaud A, Chevallier D, Amiel J, Hannoun-Levi JM. Rouscoff Y, et al. Among authors: falk at. Radiat Oncol. 2014 Jun 19;9:142. doi: 10.1186/1748-717X-9-142. Radiat Oncol. 2014. PMID: 24941956 Free PMC article.

5

Bevacizumab: A dose review.

Falk AT, Barrière J, François E, Follana P. Falk AT, et al. Crit Rev Oncol Hematol. 2015 Jun;94(3):311-22. doi: 10.1016/j.critrevonc.2015.01.012. Epub 2015 Feb 7. Crit Rev Oncol Hematol. 2015. PMID: 25703583 Review.

6

Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.

Bertin E, Benezery K, Kee DLC, François E, Evesque L, Gautier M, Gerard JP, Hannoun-Levi JM, Falk AT. Bertin E, et al. Among authors: falk at. J Contemp Brachytherapy. 2018 Dec;10(6):522-531. doi: 10.5114/jcb.2018.81025. Epub 2018 Dec 28. J Contemp Brachytherapy. 2018. PMID: 30662475 Free PMC article.

7

GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event.

Montagne L, Gal J, Chand ME, Schiappa R, Falk AT, Kinj R, Gauthier M, Hannoun-Levi JM. Montagne L, et al. Among authors: falk at. Breast Cancer Res Treat. 2019 Jul;176(1):149-157. doi: 10.1007/s10549-019-05221-z. Epub 2019 Apr 4. Breast Cancer Res Treat. 2019. PMID: 30949798

8

Radiotherapy for elderly patients and cetuximab, a monocentric study.

Falk AT, Hébert C, Tran A, Chand ME, Leysalle A, Thariat J, Dassonville O, Poissonnet G, Bozec A, Saada E, Peyrade F, Benezery K. Falk AT, et al. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1061-1065. doi: 10.1007/s00405-016-4336-3. Epub 2016 Oct 11. Eur Arch Otorhinolaryngol. 2017. PMID: 27730326

9

High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes.

Falk AT, Demontoy S, Chamorey E, Chand ME, Gautier M, Azria D, Zaki S, Chevallier D, Cham Kee DL, Hannoun-Lévi JM. Falk AT, et al. Brachytherapy. 2017 Sep-Oct;16(5):993-999. doi: 10.1016/j.brachy.2017.06.013. Epub 2017 Jul 25. Brachytherapy. 2017. PMID: 28754301

10

Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials.

Kee DLC, Gal J, Falk AT, Schiappa R, Chand ME, Gautier M, Doyen J, Hannoun-Levi JM. Kee DLC, et al. Among authors: falk at. Cancer Treat Rev. 2018 Nov;70:265-271. doi: 10.1016/j.ctrv.2018.10.004. Epub 2018 Oct 11. Cancer Treat Rev. 2018. PMID: 30326422 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters